A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study (Q73217843)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Christopher B. Granger

4

object named as

C B Granger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

C M O'Connor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

W A Gattis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Gheorghiade

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Gilbert

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J M McKenney

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F C Messineo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J C Burnett

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S D Katz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

U Elkayam

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E K Kasper

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Goldstein

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R J Cody

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

B M Massie

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

6 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1140-1148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

Natriuretic peptide system in human heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

The natriuretic-peptide family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

Atrial natriuretic peptide and its potential role in pharmacotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

New neurohormonal antagonists and atrial natriuretic peptide in the treatment of congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

Neutral endopeptidase 24.11 inhibition may not exhibit beneficial haemodynamic effects in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970081-5

10.1016/S0002-8703(99)70081-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577446%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference